ChemoCentryx
CCXI
#3569
Rank
A$5.64 B
Marketcap
A$78.45
Share price
0.00%
Change (1 day)
28.66%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: A$5.64 Billion

On November 25, 2022 ChemoCentryx had a market cap of A$5.64 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022A$5.49 B56.22%
2021A$3.51 B-36.89%
2020A$5.57 B63.79%
2019A$3.40 B333.76%
2018A$0.78 B111.06%
2017A$0.37 B-24.27%
2016A$0.49 B-0.11%
2015A$0.49 B35.5%
2014A$0.36 B30.24%
2013A$0.27 B-27.26%
2012A$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
A$37.63 B 566.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$594.43 B 10,435.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$149.89 B 2,556.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
A$165.79 B 2,838.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$758.59 B 13,345.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$266.39 B 4,621.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$216.66 B 3,740.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$52.02 B 822.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
A$371.08 B 6,477.29%๐Ÿ‡บ๐Ÿ‡ธ USA